UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K NUVATION BIO INC. (Exact name of Registrant as specified in its Charter) Delaware 85-0862255 (State or other jurisdiction of incorporation or organization) 1500 Broadway, Suite 1401 New York, New York 10036 (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 OR FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-39351 (Address of ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-13232 (Apartment Investment and Management Company) Commission file number 0-56223 (Aimco OP L.P.) Apartment Investment and Management ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-39040 AST SPACEMOBILE, INC. (Exact name of registrant as specified in its charter) Delaware 84-2027232 (State or other jurisdiction of i ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number: 1-6311 Tidewater Inc. (Exact name of registrant as specified in its charter) Delaware 72-0487776 (State of incorporation) (I.R. ...

Exhibit 99.1 Tidewater Inc. 842 West Sam Houston Parkway North, Suite 400 Houston, TX 77024, USA +1.713.470.5300 Quintin Kneen, Tidewater's President and Chief Executive Officer, commented, "Although 2025 was anticipated to be a down year for the offshore industry, I am pleased to say that by all measures Tidewater was able to successfully navigate these challenges to deliver one of the best years in recent memory, demonstrating the resilience of the company we've endeavored to build over the last eight yea ...

Financial Commitments - The company has agreed to pay Ligado Networks LLC a total of $550.0 million in cash as part of the Ligado Transaction, with $420.0 million due by October 31, 2025[5]. - The first payment of $420.0 million has already been made to Ligado for the benefit of Inmarsat[5]. - The company has entered into a loan agreement with UBS AG for a cash collateralized term loan facility of $420.0 million to finance the initial payment to Ligado[6]. Satellite Launch Plans - The average capital costs for a constellation of over 90 Block 2 BB satellites are estimated to be approximately $21.0 million to $23.0 million per satellite[2]. - The company plans to launch approximately 45 to 60 Block 2 BB satellites by the end of 2026, starting with the launch of BB6 on December 23, 2025[2]. Regulatory and Compliance Challenges - The Ligado Transaction is subject to regulatory approvals and ongoing litigation, which may impact its consummation[9]. - The company requires regulatory approvals to access necessary spectrum for providing SCS service, which may involve waivers and commercial agreements with mobile network operators (MNOs) like AT&T and Verizon[28]. - The process of obtaining governmental approvals is time-consuming and may be challenged by adverse parties, potentially delaying revenue generation[29]. - Government approvals for operating the SpaceMobile Service need periodic renewal, and there is no guarantee of renewal or compliance with applicable rules[30]. - Regulatory changes could significantly impact the company's business operations and compliance efforts[32]. Competition and Operational Risks - The company faces significant competition from existing and potential competitors in the telecommunications industry, including SpaceX's Starlink and other established service providers[16][17]. - The company may not be able to successfully launch or operate its satellites, which could adversely affect the SpaceMobile Service[20][21]. - The development of the SpaceMobile Service may face delays and cost overruns due to various factors, including technological challenges and regulatory issues[22][23]. Strategic Transactions and Market Impact - The company regularly evaluates strategic transactions, but there is no assurance that it will successfully consummate any such transactions or achieve expected results[12][13]. - The multi-class share structure may lead to a lower or more volatile market price for Class A Common Stock and could affect inclusion in major indices[33]. - Exclusion from indices could result in a less active trading market for Class A Common Stock, adversely affecting its market price[34].

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 __________________________________________ ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 001-37717 SENSEONICS HOLDINGS, INC. (Exact name of registrant as specified in its Charter) Delaware (State or other jurisdiction of ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________ to _________ Commission File Number: 001-40899 Bone Biologics Corporation (Exact name of registrant as specified in its charter) Delaware 42-1743430 (State or other j ...

Financial Performance - Q4 2025 revenue reached $319.7 million, a 22% increase from Q4 2024, marking a record performance for the fourth quarter in the company's history[6] - GAAP net income for Q4 2025 was $144.7 million, or $10.27 per diluted share, significantly up from $7.5 million in Q4 2024[6] - Total revenue for the year 2025 was $1.12 billion, up 24.2% from $900.2 million in 2024[23] - Operating income for Q4 2025 was $22.2 million, compared to $17.9 million in Q4 2024, reflecting a 23.5% increase[23] - Net income for Q4 2025 was $144.7 million, significantly up from $7.5 million in Q4 2024[23] - Adjusted EBITDA for Q4 2025 was $36.7 million, reflecting a 14% year-over-year growth[4] - Adjusted EBITDA for the twelve months ended December 31, 2025, was $132,887, representing an increase from $104,113 in the previous year[36] Revenue Segments - The Insurance segment generated $214.6 million in revenue, a 25% increase from Q4 2024, with segment profit of $48.1 million[7] - Consumer segment revenue increased by 23% year-over-year to $68.6 million, with personal loans revenue growing by 10% and Small Business revenue surging by 78%[7] - Home segment revenue was $36.2 million, a 6% increase from Q4 2024, but segment profit decreased by 11% to $10.4 million[8] Guidance and Targets - The company expects Q1 2026 revenue guidance of $317 - $325 million and full-year 2026 revenue guidance of $1,275 - $1,330 million[20] - Long-term targets include a double-digit AEBITDA growth rate and an AEBITDA/VMM ratio of 45%-50%[17] Expenses and Liabilities - Selling and marketing expenses for Q4 2025 totaled $238.3 million, a 28.2% increase from $185.9 million in Q4 2024[30] - Cash and cash equivalents at the end of Q4 2025 were $81.1 million, down from $106.6 million at the end of Q4 2024[25] - Total assets increased to $855.7 million in 2025 from $767.7 million in 2024, marking an 11.5% growth[25] - Total liabilities decreased to $568.9 million in 2025 from $658.9 million in 2024, a reduction of 13.6%[25] Shareholder Information - The weighted average shares outstanding for diluted earnings per share increased to 14.1 million in Q4 2025 from 13.6 million in Q4 2024[23] Tax and Interest - Interest expense for the three months ended December 31, 2025, was $9,394, a decrease from $17,907 in the previous quarter and an increase from $9,950 year-over-year[36] - The company reported a significant reduction in income tax benefit, with $(131,188) for the three months ended December 31, 2025, compared to $1,426 in the previous quarter[38] Company Strategy and Operations - The company plans to invest in its brand in the second half of 2026 to support its strategic framework[15] - LendingTree operates as a major online financial platform, connecting consumers with approximately 530 financial partners to access loans, credit cards, and insurance[55] - The company aims to empower consumers financially, helping them achieve better financial health through innovative products and personalized recommendations[55] - LendingTree is headquartered in Charlotte, NC, and continues to focus on expanding its market presence and enhancing its service offerings[56] Adjusted Financial Metrics - Adjusted net (loss) income excludes various non-cash expenses and one-time items, ensuring a clearer view of the company's financial performance[47] - Adjusted net (loss) income per share is calculated by dividing adjusted net (loss) income by the adjusted weighted average diluted shares outstanding, with specific considerations for potentially dilutive securities[48] - LendingTree provides GAAP measures alongside non-GAAP measures to enhance transparency and comparability[49] - There were no adjustments for one-time items in the periods presented, indicating stable financial reporting[50] - Non-cash compensation expenses primarily relate to stock grants and options, which are included in fully diluted shares calculations[51] - Amortization of intangibles, primarily from acquisitions, is excluded from adjusted EBITDA, reflecting the company's focus on operational performance[52] Risks and Forward-Looking Statements - Forward-looking statements highlight potential risks including adverse market conditions, competition, and regulatory changes that could impact future results[53]

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ______________________________________________ FORM 10-K ______________________________________________ (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-38319 ______________ ...